CD163 and neoplasm: Using CD163 mAbs conjugated with lipid NPs loaded with doxorubicin (DOX), Etzerodt et al. showed in a mouse melanoma model that selective depletion of CD163+ macrophages re-educates the TME through increased recruitment of T cells and monocytes, which both contribute to tumor regression.